BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Setrobuvir: Completed Phase IIb enrollment

Anadys disclosed in its 2Q11 earnings that the company completed enrollment of about 275 treatment-naïve and treatment-experienced patients with HCV genotype 1 in a double-blind, international Phase IIb trial comparing 200 mg oral ANA598 given twice daily plus standard...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >